Northern Trust Corp Grows Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Northern Trust Corp grew its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 29.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 863,066 shares of the company's stock after buying an additional 198,243 shares during the period. Northern Trust Corp owned 0.93% of Acadia Healthcare worth $34,221,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Lindbrook Capital LLC boosted its holdings in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock valued at $29,000 after buying an additional 671 shares in the last quarter. Blue Trust Inc. raised its position in Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after buying an additional 345 shares during the last quarter. Nisa Investment Advisors LLC boosted its stake in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after buying an additional 301 shares during the last quarter. Signaturefd LLC increased its holdings in shares of Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after purchasing an additional 1,004 shares in the last quarter. Finally, Fifth Third Bancorp increased its holdings in shares of Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock valued at $50,000 after purchasing an additional 454 shares in the last quarter.

Acadia Healthcare Trading Up 1.3%

NASDAQ:ACHC traded up $0.35 on Friday, reaching $25.99. 429,503 shares of the company's stock were exchanged, compared to its average volume of 1,694,119. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $2.39 billion, a price-to-earnings ratio of 8.50, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The business has a fifty day moving average of $26.25 and a 200-day moving average of $35.83. Acadia Healthcare Company, Inc. has a 52-week low of $20.36 and a 52-week high of $82.41.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same period in the prior year, the firm earned $0.84 earnings per share. The business's quarterly revenue was up .3% compared to the same quarter last year. As a group, analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Royal Bank of Canada cut their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Mizuho lowered their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research note on Wednesday. KeyCorp lowered their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday. Bank of America lowered their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. Finally, Barclays lowered their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday. One analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.